Back to Search
AMYLYNNE FRANKEL, M.D.
M.D.
Dermatology Physician
NPI: 1437318607IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatopathology Physician
Dermatology — Dermatopathology
Code: 207ND0900X
MD20201(ME)
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
86388(SC)
CMS Specialties
PrimaryDERMATOLOGY
Education
UNIVERSITY OF VERMONT COLLEGE OF MEDICINE
Class of 2008
Research & Publications (20)
EGFR-targeted diphtheria toxin stimulates TRAIL killing of glioblastoma cells by depleting anti-apoptotic proteins.
PMID 19449148·J Neurooncol·2009
7-preclinical
Anti-CD3 recombinant diphtheria immunotoxin therapy of cutaneous T cell lymphoma.
PMID 19199905·Curr Drug Targets·2009
6-review
Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia.
PMID 18297533·Leuk Lymphoma·2008
3-trial
Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature.
PMID 17974567·J Biol Chem·2008
7-preclinical
Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia.
PMID 16586495·Cancer·2006
3-trial
The forensic evaluation of dissociation and persons diagnosed with dissociative identity disorder: searching for convergence.
PMID 16530592·Psychiatr Clin North Am·2006
6-review
DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia.
PMID 12718740·Expert Opin Biol Ther·2003
3-trial
Diphtheria toxin conjugate therapy of cancer.
PMID 12703211·Cancer Chemother Biol Response Modif·2002
6-review
Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion protein.
PMID 12423685·Exp Hematol·2002
8-other
Diphtheria fusion protein therapy of chemoresistant malignancies.
PMID 12188918·Curr Cancer Drug Targets·2002
6-review
Peptide toxins directed at the matrix dissolution systems of cancer cells.
PMID 12141918·Protein Pept Lett·2002
6-review
New HER2-directed therapies for breast cancer. Commentary re: C. I. Spiridon et al., Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity. Clin. Cancer Res., 8: 1720-1730, 2002.
PMID 12060606·Clin Cancer Res·2002
7-preclinical
The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity.
PMID 11724789·J Biol Chem·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1650 SKYLYN DR STE 402
SPARTANBURG, SC 29307 - Phone
- (808) 798-4131
Quick Facts
- NPI
- 1437318607
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile